Looking for a specific product?

Make a search for products & suppliers, articles & news.

Individualised cancer treatment in sight

The new Centre for Cancer Biomarkers (CCBIO) at the University of Bergen will conduct in-depth studies of the microenvironment of cancerous tumours, hunting for biomarkers to aid physicians in selecting the best targeted treatment. 

Cancer today is understood as a disease with many forms. Treatment tailored to the individual may be the best way to beat it.

“This is just one of many examples,” explains CCBIO director Lars A. Akslen. “Imagine what we could spare patients and society in terms of discomfort and expenditures if we could identify beforehand which patients would benefit from a medicine! It becomes clearer every day that biomarkers are the key to making that scenario a reality.”

 

To read more, please visit the Research Council of Norway's website.

Associated companies:


Related news

Latest news

Eimskip strengthens its worldwide forwarding services by acquiring the logistics company SHIP-LOG A/S in Denmark

Eimskip has strengthened its position in worldwide logistics services by acquiring 75% of the freight forwarding company SHIP-LOG. 

For Sale Assets from the former BMV LAKSEVÄG YARD in Bergen, Norway!

For Sale Assets from the former BMV LAKSEVÄG YARD in Bergen, Norway! The entire shipbuilding and fabricating facility is closing and more than 500 lots is on sale.

Servogear CPP for Seasight II - Future of the Fjords

We are proud to announce that Servogear has been chosen for the delivery of Servogear...

TechnipFMC Signs Agreement with Pall to Supply Slurry Oil Filtration Systems for Fluid Catalytic Cracking Units

The associated activities will be managed by TechnipFMC Process Technology’s center in Houston,

10 Million kroner for verification funding

The Norwegian Research Council has granted 10 million...

Hilti acquires Oglaend System Group

Oglaend System’s headquarters will remain in Klepp, 

DOF Subsea AS ("DOF Subsea" or the "Company") today announces its intention to launch an initial public offering (the "IPO") of its ordinary shares and to apply for a listing on Oslo Børs

NOT FOR DISTRIBUTION OR RELEASE,

DOF Subsea North America extends charter for Jones Act Compliant vessel Harvey Deep Sea

The Harvey Deep Sea Vessel is a Multi-Purpose DPII Construction,

Untrue rumours about an on-going incident at the Halden Research Reactor in Norway

The Norwegian Radiation Protection Authority has become aware that stories about an ongoing incident involving a “meltdown” at the Norwegian Institute for Energy Technology (IFE) reactor situated in Halden are currently ci...